Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service medicare

Journal of the American Geriatrics Society

Volumn 58, Issue 4, 2010, Pages 674-680

  Bynum, Julie ^a,b   Song, Yunjie ^b   Fisher, Elliott ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

Elderly; Primary care; Prostate cancer; Screening; Utilization

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; AMBULATORY CARE; ARTICLE; CANCER SCREENING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MEDICARE; PRIMARY MEDICAL CARE; PROSTATE CANCER; RANDOM SAMPLE; TERMINAL CARE; UNITED STATES;

AGE FACTORS; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COST OF ILLNESS; FEE-FOR-SERVICE PLANS; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HUMANS; LIFE EXPECTANCY; MALE; MASS SCREENING; MEDICARE; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 77950439324     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02761.x     Document Type: Article

References (42)

1. Anonymous. Prostate-specific antigen (PSA) best practice policy. American Urological Association. Oncology 2000 14:267 272, 277-268, 280.
2. Smith RA, Cokkinides V, von Eschenbach AC et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002 52:8 22.
3. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008 149:185 191.
4. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence? JAMA 2003 289:1414 1420.
5. Lu-Yao G, Stukel T, Yao S-L. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 2003 95:1792 1797.
6. Farwell WR, Linder JA, Jha AK. Trends in prostate-specific antigen testing from 1995 through 2004. Arch Intern Med 2007 167:2497 2502.
7. Walter LC, Bertenthal D, Lindquist K et al. PSA screening among elderly men with limited life expectancies. JAMA 2006 296:2336 2342.
8. Skinner J, Weinstein JN, Sporer SM et al. Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients. N Engl J Med 2003 349:1350 1359.
9. Wennberg JE, Gittelsohn A, Shapiro N. Health care delivery in Maine, III: Evaluating the level of hospital performance. J Mar Med Assoc 1975 66:298 306.
10. Wennberg JE, Fisher ES, Stukel TA et al. Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States. BMJ 2004 328:607 611.
11. Wennberg JE, Fisher E, Goodman D et al. Tracking the Care of Patients with Severe Chronic Illness.
12. Earle CC, Neville BA, Landrum MB et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004 22:315 321.
13. Barnato AE, Herndon MB, Anthony DL et al. Are regional variations in end-of-life care intensity explained by patient preferences?: A study of the US medicare population. Med Care 2007 45:386 393.
14. Anthony DL, Herndon MB, Gallagher PM et al. How much do patients' preferences contribute to resource use? Health Aff 2009 28:864 873.
15. Robert Wood Johnson Foundation. Quality/Equality Press Kit: Aligning Forces for Quality. 2008 [on-line]. Available at Accessed October 19, 2008.
16. Konety BR, Cooperberg MR, Carroll PR. Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med 2009 150:220 221.
17. Gogol M. Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med 2009 150:221.
18. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: Findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008 17:636 644.
19. Walter LC, Covinsky KE. Cancer screening in elderly patients - a framework for individualized decision making. JAMA 2001 285:2750 2756.
20. Wennberg JE, Cooper MM, eds. The Dartmouth Atlas of Health Care.
21. Centers for Medicare and Medicaid Services. HCPCS - General Information. 2009 [on-line]. Available at Accessed November 23, 2009.
22. Centers for Medicare and Medicaid Services. Berenson-Eggers Type of Services [on-line]. Available at Accessed March 9, 2009.
23. Somogyi-Zalud E, Zhong Z, Hamel MB et al. The use of life-sustaining treatments in hospitalized persons aged 80 and older. J Am Geriatr Soc 2002 50:930 934.
24. Hamel MB, Lynn J, Teno JM et al. Age-related differences in care preferences, treatment decisions, and clinical outcomes of seriously ill hospitalized adults: Lessons from SUPPORT. J Am Geriatr Soc 2000 48:S176 S182.
25. Bynum JPW, Bernal-Delgado E, Gottlieb D et al. Assigning ambulatory patients and their physicians to hospitals: A method for obtaining population-based provider performance measurements. Health Serv Res 2007 42:45 62. (Pubitemid 46150943)
26. May DS, Trontell AE. Mammography use by elderly women: A methodological comparison of two national data sources. Ann Epidemiol 1998 8:439 444.
27. Schwartz LM, Woloshin S, Fowler FJ Jr. et al. Enthusiasm for cancer screening in the United States. JAMA 2004 291:71 78.
28. Han PK, Coates RJ, Uhler RJ et al. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000. Am J Prevent Med 2006 30:394 404.
29. Sirovich B, Gallagher PM, Wennberg DE et al. Discretionary Decision making by primary care physicians and the cost of U.S. health care. Health Aff 2008 27:813 823. (Pubitemid 351770251)
30. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med 1999 8:333 340.
31. Frosch DL, Kaplan RM, Felitti VJ. A randomized controlled trial comparing Internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med 2003 18:781 787.
32. Gattellari M, Ward JE. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. J Med Screen 2003 10:27 39. (Pubitemid 36560965)
33. Partin MR, Nelson D, Radosevich D et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med 2004 19:835 842. (Pubitemid 39096355)
34. Gattellari M, Ward JE. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns 2005 57:168 182. (Pubitemid 40724373)
35. Chan EC. Promoting informed decision making about prostate cancer screening. Compr Ther 2001 27:195 201.
36. Chan EC, Vernon SW, O'Donnell FT et al. Informed consent for cancer screening with prostate-specific antigen: How well are men getting the message? Am J Public Health 2003 93:779 785.
37. O'Dell KJ, Volk RJ, Cass AR et al. Screening for prostate cancer with the prostate-specific antigen test: Are patients making informed decisions? J Fam Pract 1999 48:682 688.
38. Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med 2002 113:663 667.
39. Steele CB, Miller DS, Maylahn C et al. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 2000 90:1595 1600.
40. Federman DG, Goyal S, Kamina A et al. Informed consent for PSA screening: Does it happen? Eff Clin Pract 1999 2:152 157.
41. Hoffman RM, Couper MP, Zikmund-Fisher BJ et al. Prostate cancer screening decisions: Results from the National Survey of Medical Decisions (DECISIONS Study). Arch Intern Med 2009 169:1611 1618.
42. Mathieu E, Barratt A, Davey HM et al. Informed choice in mammography screening: A randomized trial of a decision aid for 70-year-old women. Arch Intern Med 2007 167:2039 2046. (Pubitemid 350036702)